Hexagen, a biotechnology company that grew out of the University of Cambridge two years ago, has been taken over by Incyte Pharmaceuticals of the United States for Pounds 23.5 million.
Hexagen
八月 21, 1998
Hexagen, a biotechnology company that grew out of the University of Cambridge two years ago, has been taken over by Incyte Pharmaceuticals of the United States for Pounds 23.5 million.